Related Experiment Video
Updated: Dec 26, 2025
08:51
Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy
Published on: April 3, 2018
9.4K
Virus-Receptor Interactions and Virus Neutralization: Insights for Oncolytic Virus Development
Nadishka Jayawardena1, John T Poirier2, Laura N Burga1
1Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
Oncolytic Virotherapy
|March 19, 2020
Summary
Oncolytic viruses (OVs) selectively destroy cancer cells by replicating within them and triggering lysis. These agents offer advantages like localized therapeutic protein production and immune system priming for cancer treatment.
Area of Science:
- Oncology
- Virology
- Immunotherapy
Background:
- Oncolytic viruses (OVs) are engineered or naturally occurring viruses that selectively infect and replicate in cancer cells, leading to tumor cell lysis.
- This replication process releases new viral progeny, which can then infect and destroy neighboring cancer cells, creating a self-amplifying therapeutic effect.
- OVs possess the unique ability to spare normal cells, making them a promising targeted cancer therapy.
Purpose of the Study:
- To review the advancements in oncolytic virus therapy, focusing on viruses that have progressed to clinical trials.
- To elucidate the mechanisms of oncolysis, including viral replication, cell lysis, and immune system modulation.
- To discuss strategies for enhancing OV targeting of cancer cells and overcoming challenges like viral neutralization.
Main Methods:
- Review of clinical trial data and scientific literature on oncolytic viruses.
- Analysis of the molecular mechanisms underlying OV replication and cancer cell targeting.
- Examination of host-virus interactions, including viral receptors and internalization factors.
- Discussion of strategies to improve OV efficacy and overcome immune responses.
Main Results:
- OVs demonstrate selective tumor cell targeting and lysis, with potential for self-amplification within tumors.
- The efficacy of OVs can be enhanced by engineering them to carry therapeutic payloads or to evade immune detection.
- Host factors, such as differentially expressed receptors, play a crucial role in OV tropism for cancer cells.
- Viral neutralization by the host immune system remains a significant challenge, necessitating strategies to bypass it.
Conclusions:
- Oncolytic viruses represent a promising and evolving therapeutic strategy for cancer treatment.
- Further research and clinical development are essential to optimize OV delivery, efficacy, and safety, particularly in overcoming viral neutralization.
- The ability of OVs to modulate the tumor microenvironment and prime the host immune system offers a powerful platform for combination therapies.
Related Concept Videos
01:27Cytotoxic T Cells-mediated Immune Response
6.3K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.3K
01:29Immune Response Against Viral Pathogens
1.6K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.6K
01:51Mechanisms of Retrovirus-induced Cancers
6.7K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.7K
01:20Receptor-mediated Endocytosis
7.3K
Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
7.3K
02:49Cancer Therapies
9.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.7K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K